Literature DB >> 11993528

Homozygous exon 7 deletion of the SMN centromeric gene (SMN2): a potential susceptibility factor for adult-onset lower motor neuron disease.

Andoni Echaniz-Laguna1, Christophe Guiraud-Chaumeil, Christine Tranchant, André Reeber, Judith Melki, Jean-Marie Warter.   

Abstract

Mutations in the telomeric copy of the SMN gene (SMN1) are responsible for almost all infantile motor neuron disease (MND). In contrast, the role of the centromeric copy of the SMN gene (SMN2) in MND remains unclear. We searched for deletions of SMN1 and SMN2 in a group of 11 patients with sporadic adult-onset lower motor neuron disease (also referred to as "progressive muscular atrophy") and found an excess of patients carrying homozygous deletions of SMN2 exon 7 (36% versus 5% in the normal population). This result suggests that SMN2 deletions could act as a susceptibility factor for sporadic lower motor neuron disease in adults.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11993528     DOI: 10.1007/s004150200007

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  8 in total

1.  Homozygous SMN2 deletion is a protective factor in the Swedish ALS population.

Authors:  Philippe Corcia; Caroline Ingre; Helene Blasco; Rayomand Press; Julien Praline; Catherine Antar; Charlotte Veyrat-Durebex; Yves-Olivier Guettard; William Camu; Peter M Andersen; Patrick Vourc'h; Christian R Andres
Journal:  Eur J Hum Genet       Date:  2012-01-25       Impact factor: 4.246

2.  Discovery of a Small Molecule Probe That Post-Translationally Stabilizes the Survival Motor Neuron Protein for the Treatment of Spinal Muscular Atrophy.

Authors:  Anne Rietz; Hongxia Li; Kevin M Quist; Jonathan J Cherry; Christian L Lorson; Barrington G Burnett; Nicholas L Kern; Alyssa N Calder; Melanie Fritsche; Hrvoje Lusic; Patrick J Boaler; Sungwoon Choi; Xuechao Xing; Marcie A Glicksman; Gregory D Cuny; Elliot J Androphy; Kevin J Hodgetts
Journal:  J Med Chem       Date:  2017-05-19       Impact factor: 7.446

3.  Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts.

Authors:  Virginia B Mattis; Ravi Rai; Jinhua Wang; Cheng-Wei T Chang; Tristan Coady; Christian L Lorson
Journal:  Hum Genet       Date:  2006-09-02       Impact factor: 4.132

Review 4.  Skeletal muscle in motor neuron diseases: therapeutic target and delivery route for potential treatments.

Authors:  Luc Dupuis; Andoni Echaniz-Laguna
Journal:  Curr Drug Targets       Date:  2010-10       Impact factor: 3.465

5.  Identification of a novel cyclic AMP-response element (CRE-II) and the role of CREB-1 in the cAMP-induced expression of the survival motor neuron (SMN) gene.

Authors:  Sarmila Majumder; Saradhadevi Varadharaj; Kalpana Ghoshal; Umrao Monani; Arthur H M Burghes; Samson T Jacob
Journal:  J Biol Chem       Date:  2004-01-23       Impact factor: 5.157

6.  Homozygous SMN2 deletion is a major risk factor among twenty-five Korean sporadic amyotrophic lateral sclerosis patients.

Authors:  Jun-Beom Lee; Kyung-A Lee; Ji-Man Hong; Gyoung-Im Suh; Young-Chul Choi
Journal:  Yonsei Med J       Date:  2012-01       Impact factor: 2.759

7.  Muscle histopathology in today's era of molecular genetics: Role and limitations.

Authors:  Ishita Pant; Sujata Chaturvedi; Kiran Bala; Suman Kushwaha
Journal:  Ann Indian Acad Neurol       Date:  2015 Oct-Dec       Impact factor: 1.383

8.  A multi-exon-skipping detection assay reveals surprising diversity of splice isoforms of spinal muscular atrophy genes.

Authors:  Natalia N Singh; Joonbae Seo; Sarah J Rahn; Ravindra N Singh
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.